Greiner Bio-One Launches New MiniCollect® K2EDTA Capillary Tube into the Healthcare Market

07. May 2019 Greiner Bio-One is pleased to announce the launch of the newly redesigned MiniCollect® K2EDTA Capillary Collection Tube. These tubes are intended for the collection, transport and evaluation of capillary samples. The redesigned product includes an integrated scoop, allowing droplets of blood to be collected easily following skin puncture and reducing the number... Read more

Agilent Announces Unique Portfolio to Advance Immunotherapy

Agilent Announces Unique Portfolio to Advance Immunotherapy Innovative solution provides cell-based tools for translational research and development SANTA CLARA, Calif., May 7, 2019 Agilent Technologies Inc. (NYSE: A) announces a unified portfolio of products for immunotherapy researchers. The innovative solution will showcase at Immunology 2019, the 103rd Annual Meeting of the American Association of Immunologists... Read more

New Study Results Find That The Blood Biomarker MR-proADM May Prevent Early Hospital Discharge in Patients with Developing Sepsis

New Study Results Find That The Blood Biomarker MR-proADM May Prevent Early Hospital Discharge in Patients with Developing Sepsis Multi-centre analysis shows that incorporation of MR-proADM (mid-regional proadrenomedullin) into an early management of patients with suspected infection protocol may aid rapid clinical decision making in the emergency department HENNIGSDORF, Germany, May 2, 2019 /PRNewswire/ —... Read more

Beckman Coulter Expands Portfolio of Standardized ClearLLab IVD Reagents for the Clinical Flow Cytometry Lab

New 10-Color System with Kaluza C Software Streamlines Workflow and QC Reporting for Flow Cytometric Leukemia & Lymphoma* Analysis  Miami, USA (April 24, 2019) ─ Beckman Coulter is launching the ClearLLab 10C System for the clinical flow cytometry lab.  The new system is the first 10-color IVD panel of immunophenotyping reagents cleared by the Food and... Read more

Roche launches new VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer patients eligible for targeted therapy

Basel, 23 April 2019 Roche launches new VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer patients eligible for targeted therapy Nearly 2.1 million new cases of breast cancer are diagnosed worldwide each year, and more than 620,000 people will die from the disease.1 About 15 to 20 percent of women diagnosed... Read more

Elpiscience and Bio-Techne Announce Strategic Collaboration

APRIL 22, 2019 SHANGHAI and MINNEAPOLIS, April 22, 2019 /PRNewswire/ — Elpiscience BioPharma and Bio-Techne Corporation announced today that the companies have entered into a strategic collaboration for the development of anti-cancer therapeutics. Under the terms of the agreement, Elpiscience will have access to multiple antibodies from Bio-Techne’s extensive product portfolio for use in the development of preclinical, clinical, and commercial... Read more

Agilent Receives an Expanded FDA Approval for its Companion Diagnostic in NSCLC

Agilent Receives an Expanded FDA Approval for its Companion Diagnostic in NSCLC PD-L1 IHC 22C3 pharmDx Can Now Be Used to Identify a Broader Range of NSCLC Patients for First-line Treatment With KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., April 16, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has... Read more

Bruker and the Translational Metabolic Laboratory at Radboud University Medical Center Announce the Establishment of a Joint Center of Excellence for Translational Omics

Nijmegen, Netherlands, April 16, 2019 – At the opening event of the Netherlands X-omics Initiative, Bruker and the Translation Metabolic Laboratory (TML) at Radboud University Medical Center (UMC) today jointly announce the establishment of a Center of Excellence (CoE) for Translational Omics. Under the leadership of Professor Alain van Gool, the joint CoE will focus on... Read more

Thermo Fisher Scientific Announces Collaboration to Advance Noninvasive Risk Assessments of Pregnancy Outcomes

San Jose, Calif. – (April 16, 2019) – Thermo Fisher Scientific, the world leader in serving science, and NX Prenatal Inc., a recognized leader in the detection, monitoring and management of pregnancy-related complications using novel exosome-based methods, have entered into a collaboration to develop clinical mass spectrometry-based proteomics assays to monitor fetal health in utero and assess the risk... Read more

Bruker Announces Further Portfolio Expansion for Microbial Identification, Infection Control and Molecular Diagnostics of Infectious Diseases

– Reference library expansion for broader species identification by MALDI Biotyper (MBT) – Increased speed for high-throughput projects by multi-threading MBT HT software (RUO) – Increased microbial ID from positive blood cultures with improved Sepsityper™ kit – Easier subtyping for hospital hygiene and infection control with improved IR Biotyper AMSTERDAM, April 15, 2019 /PRNewswire/ — At... Read more